ONC · earnings call history
BeOne Medicines Q1 FY26 — Strong BRUKINSA Growth & Raised Full-Year Guidance
Read the briefBeOne Medicines Q4 FY25 — BRUKINSA Dominance and Pipeline Expansion
Read the briefBeOne Medicines Q3 FY25 — Strong BRUKINSA Performance and Pipeline Advancement
Read the briefBeOne Medicines AG Q4 FY24 — Strong Revenue Growth and Pipeline Advancement
Read the briefBrowse all US companies on the earnings-call register.